These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 18824140

  • 1. Effect of short-term exposure to zidovudine (AZT) on the expression of mitochondria-related genes in skeletal muscle of neonatal mice.
    Desai VG, Lee T, Moland CL, Branham WS, Von Tungeln LS, Beland FA, Fuscoe JC.
    Mitochondrion; 2009 Feb; 9(1):9-16. PubMed ID: 18824140
    [Abstract] [Full Text] [Related]

  • 2. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
    Chan SS, Santos JH, Meyer JN, Mandavilli BS, Cook DL, McCash CL, Kissling GE, Nyska A, Foley JF, van Houten B, Copeland WC, Walker VE, Witt KL, Bishop JB.
    Environ Mol Mutagen; 2007 Feb; 48(3-4):190-200. PubMed ID: 16395692
    [Abstract] [Full Text] [Related]

  • 3. Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver.
    Desai VG, Lee T, Delongchamp RR, Leakey JE, Lewis SM, Lee F, Moland CL, Branham WS, Fuscoe JC.
    Mitochondrion; 2008 Mar; 8(2):181-95. PubMed ID: 18313992
    [Abstract] [Full Text] [Related]

  • 4. Effects of short-term zidovudine exposure on mitochondrial DNA content and succinate dehydrogenase activity of rat skeletal muscle cells.
    Kiyomoto BH, Tengan CH, Godinho RO.
    J Neurol Sci; 2008 May 15; 268(1-2):33-9. PubMed ID: 18045616
    [Abstract] [Full Text] [Related]

  • 5. Frequency of Hprt mutant lymphocytes and micronucleated erythrocytes in p53-haplodeficient mice treated perinatally with AZT and AZT in combination with 3TC.
    Dobrovolsky VN, Shaddock JG, Mittelstaedt RA, Bishop ME, Lewis SM, Lee FW, Aidoo A, Leakey JE, Dunnick JK, Heflich RH.
    Environ Mol Mutagen; 2007 May 15; 48(3-4):270-82. PubMed ID: 17358030
    [Abstract] [Full Text] [Related]

  • 6. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice.
    Venerosi A, Valanzano A, Alleva E, Calamandrei G.
    Teratology; 2001 Jan 15; 63(1):26-37. PubMed ID: 11169552
    [Abstract] [Full Text] [Related]

  • 7. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment.
    Witt KL, Tice RR, Wolfe GW, Bishop JB.
    Environ Mol Mutagen; 2004 Jan 15; 44(4):321-8. PubMed ID: 15476197
    [Abstract] [Full Text] [Related]

  • 8. Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
    Diwan BA, Riggs CW, Logsdon D, Haines DC, Olivero OA, Rice JM, Yuspa SH, Poirier MC, Anderson LM.
    Toxicol Appl Pharmacol; 1999 Nov 15; 161(1):82-99. PubMed ID: 10558926
    [Abstract] [Full Text] [Related]

  • 9. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver.
    de la Asunción JG, del Olmo ML, Sastre J, Pallardó FV, Viña J.
    Hepatology; 1999 Mar 15; 29(3):985-7. PubMed ID: 10051507
    [Abstract] [Full Text] [Related]

  • 10. Metabolic abnormalities in skeletal muscle of patients receiving zidovudine therapy observed by 31P in vivo magnetic resonance spectroscopy.
    Sinnwell TM, Sivakumar K, Soueidan S, Jay C, Frank JA, McLaughlin AC, Dalakas MC.
    J Clin Invest; 1995 Jul 15; 96(1):126-31. PubMed ID: 7615782
    [Abstract] [Full Text] [Related]

  • 11. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M, Walker UA, Sevastianova K, Setzer B, Wågsäter D, Eriksson P, Yki-Järvinen H, Sutinen J.
    J Infect Dis; 2009 Jul 15; 200(2):252-62. PubMed ID: 19519254
    [Abstract] [Full Text] [Related]

  • 12. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
    Von Tungeln LS, Williams LD, Doerge DR, Shaddock JG, McGarrity LJ, Morris SM, Mittelstaedt RA, Heflich RH, Beland FA.
    Environ Mol Mutagen; 2007 Jul 15; 48(3-4):258-69. PubMed ID: 16850453
    [Abstract] [Full Text] [Related]

  • 13. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.
    Gerschenson M, Erhart SW, Paik CY, St Claire MC, Nagashima K, Skopets B, Harbaugh SW, Harbaugh JW, Quan W, Poirier MC.
    AIDS Res Hum Retroviruses; 2000 May 01; 16(7):635-44. PubMed ID: 10791874
    [Abstract] [Full Text] [Related]

  • 14. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats.
    Walker DM, Malarkey DE, Seilkop SK, Ruecker FA, Funk KA, Wolfe MJ, Treanor CP, Foley JF, Hahn FF, Hardisty JF, Walker VE.
    Environ Mol Mutagen; 2007 May 01; 48(3-4):283-98. PubMed ID: 17358026
    [Abstract] [Full Text] [Related]

  • 15. Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants.
    Côté HC, Raboud J, Bitnun A, Alimenti A, Money DM, Maan E, Costei A, Gadawski I, Diong C, Read S, Shen S, Harrigan PR, Burdge DR, King SM, Forbes JC.
    J Infect Dis; 2008 Sep 15; 198(6):851-9. PubMed ID: 18684095
    [Abstract] [Full Text] [Related]

  • 16. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model.
    Lamperth L, Dalakas MC, Dagani F, Anderson J, Ferrari R.
    Lab Invest; 1991 Dec 15; 65(6):742-51. PubMed ID: 1753716
    [Abstract] [Full Text] [Related]

  • 17. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
    Olivero OA, Tejera AM, Fernandez JJ, Taylor BJ, Das S, Divi RL, Poirier MC.
    Mutagenesis; 2005 Mar 15; 20(2):139-46. PubMed ID: 15784690
    [Abstract] [Full Text] [Related]

  • 18. [Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats].
    Zhu B, Zhu ZN, Wang JZ, Huang SM, Feng XM, Li AY, Yang DL, Wang BJ.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct 15; 20(10):794-7. PubMed ID: 23207344
    [Abstract] [Full Text] [Related]

  • 19. Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine.
    Gerschenson M, Nguyen V, Ewings EL, Ceresa A, Shaw JA, St Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Olivero OA, Divi RL, Albert PS, Poirier MC.
    AIDS Res Hum Retroviruses; 2004 Jan 15; 20(1):91-100. PubMed ID: 15000702
    [Abstract] [Full Text] [Related]

  • 20. Zidovudine [AZT] myotoxicity: quantitative separation of AZT effects on proliferation and differentiation of muscle cells in vitro. Lack of myotoxicity potentiation by retrovirus.
    Waclawik AJ, Vann J, Schmelz G, Szurek P, Lewandoski P, Brooks BR.
    Neurotoxicology; 1999 Feb 15; 20(1):49-56. PubMed ID: 10091858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.